ÂÜÀòÂÒÂ×

Elodie Angot is an accomplished neuroscientist with extensive experience in pharmacology and research leadership. Currently serving as Principal Scientist, Lab Head, and Research Project Leader at Roche since January 2023, Elodie previously held notable positions at Idorsia Pharmaceuticals Ltd from June 2017 to November 2022, where activities included setting up in vitro and in vivo models for neurological conditions. Prior to that, Elodie worked at Actelion as Lab Head for CNS in vivo pharmacology, focusing on neurodegeneration and neuroinflammation. Elodie also led a team at Lund University's Wallenberg Neuroscience Center, specializing in neurodegenerative diseases, and completed a PhD in Signal Transduction and Developmental Neuropharmacology at CNRS. Academic qualifications include a Ph.D. from Paris-Sud University and various MSc degrees in relevant fields, underlining Elodie's strong foundation in neuroscience and biochemistry.